Merck & Company Inc (MRK) Stock Forecast & Price Target
Merck & Company Inc · NYSE
$131.84+1.08 (+0.83%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 19 firms covering Merck & Company Inc, 12 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $90.00 to $155.00, a moderate spread. The average target of $131.78 is roughly in line with the current $131.84. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 11 to 12 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.28 next quarter toward $9.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS19 ratings
Moderate Buy
Strong Buy00%
Buy1263%
Hold737%
Sell00%
Strong Sell00%
Based on 19 analysts giving stock ratings to Merck & Company Inc.
As of Jul, 12 of 19 firms rate MRK a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MRK EPS & revenue forecast
EPS · NEXT QUARTER
$2.28
Range $2.11 – $2.49 · 14 analysts · -12% YoY
Next period, 14 analysts expect Merck & Company Inc to earn $2.28 a share (range $2.11 – $2.49), versus $2.58 a year earlier. Full-year consensus is $2.74, growing to $9.66 the year after.
REVENUE · NEXT QUARTER
$17.3B
Range $16.9B – $18.0B · 14 analysts · +0% YoY
Revenue is expected to reach $17.3B (range $16.9B – $18.0B), +0.3% year-over-year. Full-year consensus is $66.9B, rising to $70.1B next year.
Top analysts covering Merck & Company Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MRK.
#1
Jason Gerberry
B of A Securities · Rank #136
Buy
$130.00-1.4% to target
Overall win rate
46%
+ Follow
#2
Geoff Meacham
Citigroup
Hold
$125.00-5.2% to target
Coverage
—
+ Follow
#3
TH
Trung Huynh
RBC Capital
Buy
$142.00+7.7% to target
Coverage
—
+ Follow
#4
Mohit Bansal
Wells Fargo
Buy
$150.00+13.8% to target
Coverage
—
+ Follow
#5
Vamil Divan
Guggenheim
Buy
$145.00+10.0% to target
Coverage
—
+ Follow
MRK stock forecast FAQ
What is MRK's average 12-month price target?+
The 17 analysts with a live target average $131.78 for Merck & Company Inc over the next 12 months, ranging from a $155.00 high to a $90.00 low.
Is MRK stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 19 analyst ratings, 12 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for MRK?+
The Street-high target is $155.00 (Scotiabank), and the Street-low is $90.00 (Berenberg). The average of all 17 active targets is $131.78.
How many Wall Street analysts cover MRK?+
19 analysts have an active rating on Merck & Company Inc, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering MRK?+
Among analysts who currently cover MRK, Jason Gerberry of B of A Securities has the strongest overall Quantellect track record (Rank #136). Their current call is Buy with a $130.00 target.
What is Merck & Company Inc's projected EPS for next quarter?+
The consensus estimate is $2.28 per share (range $2.11 – $2.49) across 14 analysts. Full-year EPS is projected at $2.74, rising to $9.66 the following year.
How much revenue is Merck & Company Inc expected to report next quarter?+
Consensus revenue is $17.3B (range $16.9B – $18.0B). Full-year revenue is projected at $66.9B, growing to $70.1B next year.
Have analysts been upgrading or downgrading MRK lately?+
As of Jul, 12 of 19 firms rate MRK a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MRK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
